Semaglutide medications like Ozempic and Wegovy help regulate blood sugar and body weight by acting on the brain to increase fullness and decrease appetite, reducing body weight by an average of 15 per cent over 68 weeks when combined with lifestyle interventions, The Conversation reported. However, these treatments do not work the same way for everyone, prompting researchers to investigate energy metabolism as a key factor in weight loss plateaus.
University of Alberta Research Teams Investigate Energy Metabolism
At the University of Alberta, a group of specialists from various fields is striving to enhance obesity treatment across all age groups. Researchers want to understand why individual patients respond differently to semaglutide and how successful weight loss can be maintained over time. According to Obesity Canada, these medications represent important pillars in obesity management and should be monitored as part of a comprehensive, multidisciplinary approach to care.
Investigators are exploring whether individual responses to these treatments stem from genetics, metabolism, body composition, lifestyle, microbiota, associated diseases, age, and sex. Weight loss serves as only one measure of treatment success. Clinical observations show that these therapies also improve quality of life, strength, blood markers such as sugar and cholesterol, and overall health.
Metabolic Adaptation Triggers Weight Loss Plateaus
Energy metabolism measures the total calories consumed and the total calories burned through vital processes, physical activity, and food digestion. When people lose weight, their bodies naturally require less energy to function. Sometimes, however, the body enters an extra energy-saving mode, burning even fewer calories than expected. This phenomenon is known as metabolic adaptation or adaptive thermogenesis.
This process acts like a light bulb that automatically dims to save electricity. Changes in body weight and composition, including both fat and fat-free mass, drive this energy shift. Because both types of tissue burn energy even at rest, losing them causes the body to burn fewer calories overall.
Whole-Room Indirect Calorimeter Measures Energy Utilization
Researchers at the University of Alberta use a rare, gold-standard facility called a whole-room indirect calorimeter to study these changes. Resembling a hotel suite, the room precisely measures each component of human energy use. It isolates the effects of calorie burning at rest, after eating, and during exercise.
The facility is presently seeking volunteers who are preparing to begin semaglutide therapy and experience difficulties with blood sugar control, including diabetes or insulin resistance. Investigators will track these participants over six months. This work aims to explain why certain individuals do not lose weight on the medication, allowing clinicians to offer alternative treatments sooner.
Lifestyle Changes Optimize Body Composition Results
Current guidelines from Obesity Canada recommend specific lifestyle modifications for individuals taking or considering semaglutide. To enhance their diet, patients need to eat more protein and focus on wholesome, fresh foods like vegetables, fruits, whole grains, nuts, seeds, and lean meats such as poultry and fish.
Additional recommendations include eating small portions at consistent times, avoiding skipped meals, paying attention to hunger and fullness cues, and choosing water as a primary beverage. Current guidelines also urge patients to engage in resistance exercise to support muscle and bone health, which helps limit reductions in energy use during weight loss.
Frequently Asked Questions About Semaglutide Treatment
How does semaglutide affect resting energy use?
Recent reviews of studies investigating GLP-1 therapies found that findings regarding resting energy use remain neutral or inconclusive. The question of how semaglutide impacts energy use is an emerging area of study that requires further exploration.
Who is eligible for the University of Alberta study?
The research facility is actively recruiting participants who have blood sugar regulation issues, including insulin resistance or diabetes, and who are about to begin semaglutide treatment.
What exercise is recommended while taking semaglutide?
Health guidelines recommend that people using GLP-1 medications engage in resistance exercise to optimize body composition, support muscle and bone health, and achieve the best results.